NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against TransMedics Group, Inc (“TransMedics” or the “Company”) (NYSE: TMDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…

NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Venture Global, Inc (“Venture Global” or the “Company”) (NYSE: VG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…

// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Feb. 18, 2025 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (“BioVaxys” or “Company”) announces that it has entered into debt settlement agreements…